• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N6-甲基腺苷甲基转移酶组件 KIAA1429 是癌症治疗的潜在靶点。

N6-Methyladenosine Methyltransferase Component KIAA1429 Is a Potential Target of Cancer Therapy.

机构信息

State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan 430072, China.

Department of Endodontics, School & Hospital of Stomatology, Wuhan University, Wuhan 430072, China.

出版信息

Biomolecules. 2024 Oct 17;14(10):1319. doi: 10.3390/biom14101319.

DOI:10.3390/biom14101319
PMID:39456252
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11506059/
Abstract

N6-methyladenosine (mA), the most abundant RNA modification in eukaryotes, has a crucial impact on tumorigenesis. KIAA1429 is the key component of the mA methyltransferase complex, in which KIAA1429 functions as a scaffold to bridge the catalytic core proteins. KIAA1429 is often overexpressed in malignances, associated with patient prognosis, and required for tumorigenesis. KIAA1429 regulates the expression of a number of tumor-associated genes in an mA -dependent manner, and thus, contributes to cell proliferation, migration, drug resistance, tumor formation and metastasis. This review focuses on recent progress in the understanding of roles and mechanisms of KIAA1429 in cancers, and offers ideas for potential anti-cancer therapeutic methods by targeting KIAA1429.

摘要

N6-甲基腺苷(mA)是真核生物中最丰富的 RNA 修饰物,对肿瘤发生有重要影响。KIAA1429 是 mA 甲基转移酶复合物的关键组成部分,其中 KIAA1429 作为支架,连接催化核心蛋白。KIAA1429 在恶性肿瘤中常过度表达,与患者预后相关,并且是肿瘤发生所必需的。KIAA1429 以 mA 依赖性方式调节许多与肿瘤相关基因的表达,从而促进细胞增殖、迁移、耐药、肿瘤形成和转移。本综述重点介绍了近年来对 KIAA1429 在癌症中的作用和机制的理解进展,并提供了通过靶向 KIAA1429 作为潜在的抗癌治疗方法的思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e34/11506059/f32e28af4469/biomolecules-14-01319-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e34/11506059/13a63b15a87b/biomolecules-14-01319-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e34/11506059/16c395b2ba93/biomolecules-14-01319-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e34/11506059/51f8cc03e632/biomolecules-14-01319-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e34/11506059/f32e28af4469/biomolecules-14-01319-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e34/11506059/13a63b15a87b/biomolecules-14-01319-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e34/11506059/16c395b2ba93/biomolecules-14-01319-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e34/11506059/51f8cc03e632/biomolecules-14-01319-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e34/11506059/f32e28af4469/biomolecules-14-01319-g004.jpg

相似文献

1
N6-Methyladenosine Methyltransferase Component KIAA1429 Is a Potential Target of Cancer Therapy.N6-甲基腺苷甲基转移酶组件 KIAA1429 是癌症治疗的潜在靶点。
Biomolecules. 2024 Oct 17;14(10):1319. doi: 10.3390/biom14101319.
2
KIAA1429 Induces m6A Modification of LINC01106 to Enhance the Malignancy of Lung Adenocarcinoma Cells via the JAK/STAT3 Pathway.KIAA1429 通过 JAK/STAT3 通路诱导 LINC01106 的 m6A 修饰来增强肺腺癌细胞的恶性程度。
Crit Rev Immunol. 2024;44(6):49-61. doi: 10.1615/CritRevImmunol.2024052728.
3
Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma.基因扩增驱动的 RNA 甲基转移酶 KIAA1429 通过 m6A-YTHDF2 依赖途径调节 BTG2 促进肺腺癌的发生。
Cancer Commun (Lond). 2022 Jul;42(7):609-626. doi: 10.1002/cac2.12325. Epub 2022 Jun 21.
4
KIAA1429 is a potential prognostic marker in colorectal cancer by promoting the proliferation via downregulating WEE1 expression in an m6A-independent manner.KIAA1429 通过以 m6A 非依赖方式下调 WEE1 表达促进增殖,成为结直肠癌的一个潜在预后标志物。
Oncogene. 2022 Jan;41(5):692-703. doi: 10.1038/s41388-021-02066-z. Epub 2021 Nov 24.
5
KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3.KIAA1429 通过 GATA3 的 N6-甲基腺苷依赖性转录后修饰促进肝癌进展。
Mol Cancer. 2019 Dec 19;18(1):186. doi: 10.1186/s12943-019-1106-z.
6
N-methyladenosine methyltransferase KIAA1429 elevates colorectal cancer aerobic glycolysis via HK2-dependent manner.N6-甲基腺苷甲基转移酶 KIAA1429 通过 HK2 依赖性方式促进结直肠癌细胞有氧糖酵解。
Bioengineered. 2022 May;13(5):11923-11932. doi: 10.1080/21655979.2022.2065952.
7
N6-methyladenosine methyltransferases: functions, regulation, and clinical potential.N6-甲基腺苷甲基转移酶:功能、调控及临床潜力。
J Hematol Oncol. 2021 Jul 27;14(1):117. doi: 10.1186/s13045-021-01129-8.
8
Circular RNA circ_KIAA1429 accelerates hepatocellular carcinoma progression via the miR-133a-3p/high mobility group AT-hook 2 (HMGA2) axis in an m6A-dependent manner.环状 RNA circ_KIAA1429 通过 m6A 依赖性方式经由 miR-133a-3p/高迁移率族 AT 钩状结构域 2 (HMGA2) 轴促进肝细胞癌进展。
Hum Cell. 2023 Sep;36(5):1741-1754. doi: 10.1007/s13577-023-00933-3. Epub 2023 Jun 27.
9
KIAA1429 acts as an oncogenic factor in breast cancer by regulating CDK1 in an N6-methyladenosine-independent manner.KIAA1429 通过非 N6-甲基腺苷依赖方式调控 CDK1 发挥致癌因子作用在乳腺癌中。
Oncogene. 2019 Aug;38(33):6123-6141. doi: 10.1038/s41388-019-0861-z. Epub 2019 Jul 8.
10
KIAA1429 promotes gastric cancer progression by destabilizing RASD1 mRNA in an mA-YTHDF2-dependent manner.KIAA1429 通过依赖于 mA-YTHDF2 的方式来破坏 RASD1 mRNA 的稳定性,从而促进胃癌的进展。
J Transl Med. 2024 Jun 20;22(1):584. doi: 10.1186/s12967-024-05375-5.

引用本文的文献

1
M6A RNA modification: focusing on non-small cell lung cancer progression, therapeutic strategies and challenges.m6A RNA修饰:聚焦于非小细胞肺癌的进展、治疗策略及挑战
Front Oncol. 2025 Jul 16;15:1622359. doi: 10.3389/fonc.2025.1622359. eCollection 2025.
2
The Multifaceted Role of VIRMA, a Core Component of the Methyltransferase Complex, in Cancer and Cancer Therapy.VIRMA(甲基转移酶复合物的核心成分)在癌症及癌症治疗中的多方面作用
Biomolecules. 2025 Jun 22;15(7):912. doi: 10.3390/biom15070912.
3
Total m6A RNA levels and VIRMA expression as potential diagnostic and prognostic markers in oral squamous cell carcinoma.

本文引用的文献

1
KIAA1429 increases FOXM1 expression through YTHDF1-mediated m6A modification to promote aerobic glycolysis and tumorigenesis in multiple myeloma.KIAA1429 通过 YTHDF1 介导的 m6A 修饰增加 FOXM1 的表达,从而促进多发性骨髓瘤中的有氧糖酵解和肿瘤发生。
Cell Biol Toxicol. 2024 Jul 26;40(1):58. doi: 10.1007/s10565-024-09904-2.
2
Inhibition of KIAA1429/HK1 axis enhances the sensitivity of liver cancer cells to sorafenib by regulating the Warburg effect.抑制 KIAA1429/HK1 轴通过调节瓦博格效应增强肝癌细胞对索拉非尼的敏感性。
Biochem Pharmacol. 2024 Sep;227:116419. doi: 10.1016/j.bcp.2024.116419. Epub 2024 Jul 10.
3
总m6A RNA水平和VIRMA表达作为口腔鳞状细胞癌潜在的诊断和预后标志物。
Diagn Pathol. 2025 Jul 3;20(1):81. doi: 10.1186/s13000-025-01678-3.
KIAA1429 promotes gastric cancer progression by destabilizing RASD1 mRNA in an mA-YTHDF2-dependent manner.
KIAA1429 通过依赖于 mA-YTHDF2 的方式来破坏 RASD1 mRNA 的稳定性,从而促进胃癌的进展。
J Transl Med. 2024 Jun 20;22(1):584. doi: 10.1186/s12967-024-05375-5.
4
KIAA1429 regulates lung adenocarcinoma proliferation and metastasis through the PI3K/AKT pathway by modulating ARHGAP30 expression.KIAA1429 通过调节 ARHGAP30 的表达,通过 PI3K/AKT 通路调控肺腺癌的增殖和转移。
Thorac Cancer. 2024 Jun;15(18):1397-1409. doi: 10.1111/1759-7714.15327. Epub 2024 May 8.
5
The m6 RNA methylation regulator KIAA1429 is associated with autophagy-mediated drug resistance in lung cancer.m6 RNA甲基化调节因子KIAA1429与肺癌中自噬介导的耐药性相关。
FASEB Bioadv. 2024 Mar 15;6(4):105-117. doi: 10.1096/fba.2023-00083. eCollection 2024 Apr.
6
Inhibin A contributes to the tumorigenesis of oral squamous cell carcinoma by KIAA1429-mediated m6A modification.抑制素 A 通过 KIAA1429 介导的 m6A 修饰促进口腔鳞状细胞癌的发生。
J Oral Pathol Med. 2024 Apr;53(4):266-274. doi: 10.1111/jop.13531. Epub 2024 Mar 26.
7
KIAA1429-mediated RXFP1 attenuates non-small cell lung cancer tumorigenesis via N6-methyladenosine modification.KIAA1429介导的RXFP1通过N6-甲基腺苷修饰减弱非小细胞肺癌的肿瘤发生。
Cancer Biomark. 2024 Feb 7:CBM230188. doi: 10.3233/CBM-230188.
8
KIAA1429 facilitates metastasis via m6A-YTHDC1-dependent RND3 down-regulation in hepatocellular carcinoma cells.KIAA1429 通过 m6A-YTHDC1 依赖的 RND3 下调促进肝癌细胞转移。
Cancer Lett. 2024 Mar 1;584:216598. doi: 10.1016/j.canlet.2023.216598. Epub 2024 Jan 14.
9
An overview of the functions of p53 and drugs acting either on wild- or mutant-type p53.p53 功能概述以及针对野生型或突变型 p53 的药物作用。
Eur J Med Chem. 2024 Feb 5;265:116121. doi: 10.1016/j.ejmech.2024.116121. Epub 2024 Jan 3.
10
Clinical Significance and Potential Mechanisms of the RNA Methyltransferase KIAA1429 in Osteosarcoma.RNA甲基转移酶KIAA1429在骨肉瘤中的临床意义及潜在机制
J Cancer. 2024 Jan 1;15(1):126-139. doi: 10.7150/jca.86630. eCollection 2024.